161 related articles for article (PubMed ID: 38441657)
21. Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.
Lorusso D; Colombo N; Herraez AC; Santin AD; Colomba E; Miller DS; Fujiwara K; Pignata S; Baron-Hay SE; Ray-Coquard IL; Shapira-Frommer R; Kim YM; McCormack M; Massaad R; Nguyen AM; Zhao Q; McKenzie J; Prabhu VS; Makker V
Eur J Cancer; 2023 Jun; 186():172-184. PubMed ID: 37086595
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072).
Coens C; van der Graaf WT; Blay JY; Chawla SP; Judson I; Sanfilippo R; Manson SC; Hodge RA; Marreaud S; Prins JB; Lugowska I; Litière S; Bottomley A
Cancer; 2015 Sep; 121(17):2933-41. PubMed ID: 26033286
[TBL] [Abstract][Full Text] [Related]
23. The impact on health-related quality of a stoma or poor functional outcomes after rectal cancer surgery in Dutch patients: A prospective cohort study.
van Kooten RT; Algie JPA; Tollenaar RAEM; Wouters MWJM; Putter H; Peeters KCMJ; Dekker JWT
Eur J Surg Oncol; 2023 Sep; 49(9):106914. PubMed ID: 37105868
[TBL] [Abstract][Full Text] [Related]
24. Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.
Motzer R; Porta C; Alekseev B; Rha SY; Choueiri TK; Mendez-Vidal MJ; Hong SH; Kapoor A; Goh JC; Eto M; Bennett L; Wang J; Pan JJ; Saretsky TL; Perini RF; He CS; Mody K; Cella D
Lancet Oncol; 2022 Jun; 23(6):768-780. PubMed ID: 35489363
[TBL] [Abstract][Full Text] [Related]
25. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Rischin D; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Braña I; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Ishak WZW; Hong RL; Mendoza RG; Jia L; Chirovsky D; Norquist J; Jin F; Burtness B
Oral Oncol; 2022 May; 128():105815. PubMed ID: 35381576
[TBL] [Abstract][Full Text] [Related]
26. Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial).
Park J; Danielsen AK; Angenete E; Bock D; Marinez AC; Haglind E; Jansen JE; Skullman S; Wedin A; Rosenberg J
Br J Surg; 2018 Feb; 105(3):244-251. PubMed ID: 29168881
[TBL] [Abstract][Full Text] [Related]
27. Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study.
Schmid P; Lipatov O; Im SA; Goncalves A; Muñoz-Couselo E; Lee KS; Tamura K; Testa L; Witzel I; Ohtani S; Turner N; Zambelli S; Harbeck N; Andre F; Dent R; Mejia JA; Zhou X; Haiderali A; Nguyen AM; Cortes J; Winer EP
Eur J Cancer; 2023 Dec; 195():113393. PubMed ID: 37976633
[TBL] [Abstract][Full Text] [Related]
28. Life after surgical resection of a low-grade glioma: A prospective cross-sectional study evaluating health-related quality of life.
Teng KX; Price B; Joshi S; Alukaidey L; Shehab A; Mansour K; Toor GS; Angliss R; Drummond K
J Clin Neurosci; 2021 Jun; 88():259-267. PubMed ID: 33992194
[TBL] [Abstract][Full Text] [Related]
29. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
Grande GE; Farquhar MC; Barclay SI; Todd CJ
Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
[TBL] [Abstract][Full Text] [Related]
30. The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).
McLachlan SA; Fisher RJ; Zalcberg J; Solomon M; Burmeister B; Goldstein D; Leong T; Ackland SP; McKendrick J; McClure B; Mackay J; Ngan SY
Eur J Cancer; 2016 Mar; 55():15-26. PubMed ID: 26771873
[TBL] [Abstract][Full Text] [Related]
31. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
[TBL] [Abstract][Full Text] [Related]
32. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer.
Camilleri-Brennan J; Steele RJ
Br J Surg; 2001 Dec; 88(12):1617-22. PubMed ID: 11736975
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values.
Amin S; Joo S; Nolte S; Yoo HK; Patel N; Byrnes HF; Costa-Cabral S; Johnson CD
BMC Cancer; 2022 May; 22(1):563. PubMed ID: 35596182
[TBL] [Abstract][Full Text] [Related]
34. Quality of life in very elderly radiotherapy patients: a prospective pilot study using the EORTC QLQ-ELD14 module.
Kaufmann A; Schmidt H; Ostheimer C; Ullrich J; Landenberger M; Vordermark D
Support Care Cancer; 2015 Jul; 23(7):1883-92. PubMed ID: 25475738
[TBL] [Abstract][Full Text] [Related]
35. The effect of age on health-related quality of life for head and neck cancer patients up to 1 year after curative treatment.
Berg M; Silander E; Bove M; Johansson L; Nyman J; Hammerlid E
J Geriatr Oncol; 2022 Jan; 13(1):60-66. PubMed ID: 34244112
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.
Gao Y; Rosas JC; Fink H; Behrens S; Chang-Claude J; Seibold P
Qual Life Res; 2023 Sep; 32(9):2639-2652. PubMed ID: 37093543
[TBL] [Abstract][Full Text] [Related]
37. Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
Abozaid M; Tan WS; Khetrapal P; Baker H; Duncan J; Sridhar A; Briggs T; Selim M; Abdallah MM; Elmahdy AA; Elserafy F; Kelly JD
BJU Int; 2022 Jan; 129(1):72-79. PubMed ID: 34092021
[TBL] [Abstract][Full Text] [Related]
38. Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial.
Velenik V; Zadnik V; Omejc M; Grosek J; Tuta M
Radiol Oncol; 2020 Aug; 54(4):461-469. PubMed ID: 32738130
[TBL] [Abstract][Full Text] [Related]
39. Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
Ballhausen A; Karthaus M; Fruehauf S; Graeven U; Müller L; König AO; von Weikersthal LF; Sommerhäuser G; Alig AHS; Goekkurt E; Meyer-Knees JW; Kurreck A; Stahler A; Held S; Kasper S; Heinrich K; Heinemann V; Stintzing S; Trarbach T; Modest DP
Eur J Cancer; 2023 Sep; 190():112955. PubMed ID: 37454537
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Postoperative Complications on Short- and Long-Term Health-Related Quality of Life After Total Mesorectal Excision for Rectal Cancer.
van Kooten RT; Elske van den Akker-Marle M; Putter H; Meershoek-Klein Kranenbarg E; van de Velde CJH; Wouters MWJM; Tollenaar RAEM; Peeters KCMJ
Clin Colorectal Cancer; 2022 Dec; 21(4):325-338. PubMed ID: 36210321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
